Code is only used for female patients. C54.1 is a billable ICD code used to specify a diagnosis of malignant neoplasm of endometrium. A 'billable code' is detailed enough to be used to specify a medical diagnosis. Endometrial cancer is a cancer that arises from the endometrium (the lining of the uterus or womb).
C53 ICD-10-CM Diagnosis Code C53. Malignant neoplasm of cervix uteri 2016 2017 2018 2019 Non-Billable/Non-Specific Code. Type 1 Excludes carcinoma in situ of cervix uteri (D06.-) Malignant neoplasm of cervix uteri.
Cancer that forms in tissues of the uterus (the small, hollow, pear-shaped organ in a woman's pelvis in which a fetus develops). Two types of uterine cancer are endometrial cancer (cancer that begins in cells lining the uterus) and uterine sarcoma (a rare cancer that begins in muscle or other tissues in the uterus).
The default code for cases coded in ICD-O first edition and converted electronically is C54.9. If more specific coding is desired, the text describing the primary site should be reviewed to assign the case to endometrium (C54.1) or another sub site.
C54. 1 - Malignant neoplasm of endometrium. ICD-10-CM.
Adenocarcinoma. This type makes up the majority of uterine cancers. It develops from cells in the endometrium. This cancer is commonly called endometrial cancer. One common endometrial adenocarcinoma subtype is called endometrioid carcinoma.
Most endometrial cancers are adenocarcinomas, and endometrioid cancer is the most common type of adenocarcinoma, by far. Endometrioid cancers start in gland cells and look a lot like the normal uterine lining (endometrium).
ICD-10 code: C55 Malignant neoplasm of uterus, part unspecified.
Endometrial cancer starts in the lining of the uterus — the endometrium. Being overweight or obese greatly increases a woman's chance of developing endometrial cancer. Other risk factors include age, family history, a diagnosis of polycystic ovary syndrome and prior use of the breast cancer treatment drug tamoxifen.
Endometrial adenocarcinoma is the third common malignancy of the female genital tract occurring most often in the postmenopausal age group. High tumor grade, advanced surgical stage, and lymphovascular space invasion are implicated as poor prognostic factors for dissemination of disease.
Cancer that forms in the glandular tissue, which lines certain internal organs and makes and releases substances in the body, such as mucus, digestive juices, and other fluids. Most cancers of the breast, lung, esophagus, stomach, colon, rectum, pancreas, prostate, and uterus are adenocarcinomas.
Uterine cancer is a disease in which cancer cells form in the tissues of the uterus (womb). There are two primary types of uterine cancer: endometrial cancer, which is more common, and uterine sarcoma, which is rare. In endometrial cancer, cancer cells form in the endometrium, which is the lining of the uterus.
Abstract. Uterine serous adenocarcinoma (USC) is rare and invasive cancer. This cancer is more often reported in the ovary, the fallopian tube, and the endometrium than uterine cervix. No matter where the tumor is located, the tumor exhibits similar histological characteristics.
N85. 2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Uterine leiomyosarcoma (LMS) is a rare uterine malignancy that arises from the smooth muscle of the uterine wall. Compared with other types of uterine cancers, LMS is an aggressive tumor associated with a high risk of recurrence and death, regardless of stage at presentation [1].
Leiomyosarcoma, or LMS, is a type of rare cancer that grows in the smooth muscles. The smooth muscles are in the hollow organs of the body, including the intestines, stomach, bladder, and blood vessels. In females, there is also smooth muscle in the uterus.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
Approximate Synonyms. Adenocarcinoma of endometrium. Cancer of the endometrium. Cancer of the endometrium, adenocarcinoma. Cancer of the endometrium, adenosquamous. Cancer of the endometrium, clear cell. Cancer of the endometrium, mixed mullerian. Cancer of the endometrium, papillary serous.